Changes in the human visual evoked potential caused by the anticholinergic agent hyoscine hydrobromide: Comparison with results in Alzheimer's disease

68Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

The anticholinergic drug hydrobromide produced a slowing of the P2 and N3 components of the flash visual evoked potential (VEP) in young normals but did not affect the pattern reversal VEP. These results, which are similar to those found in Alzheimer's disease, could be explained by an underlying defect of the cholinergic system.

Cite

CITATION STYLE

APA

Bajalan, A. A. A., Wright, C. E., & Van Der Vliet, V. J. (1986). Changes in the human visual evoked potential caused by the anticholinergic agent hyoscine hydrobromide: Comparison with results in Alzheimer’s disease. Journal of Neurology Neurosurgery and Psychiatry, 49(2), 175–182. https://doi.org/10.1136/jnnp.49.2.175

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free